Autoimmune hepatitis and overlap syndromes
Clinics in Liver Disease, ISSN: 1089-3261, Vol: 6, Issue: 2, Page: 349-362
2002
- 51Citations
- 17Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations51
- Citation Indexes51
- 51
- CrossRef40
- Captures17
- Readers17
- 17
Review Description
Autoimmune hepatitis (AIH) is an immune-mediated, autodestructive liver disease with hepatocytes as target cells, mostly affecting young women. Primary biliary cirrhosis (PBC) is also regarded as an autoimmune liver disease with bile duct epithelia as the target cells, resulting in a continuous loss of bile ducts. Both diseases may occur simultaneously in their full manifestations in about 10% to 20% of cases, thus constituting an overlap syndrome with PBC directing the course of the disease. AIH may also occur simultaneously with primary sclerosing cholangitis (PSC), with a frequency of between 2% and 8% of patients with PSC. In most cases, AIH precedes manifestation of PSC. In children, the overlap syndrome of AIH and PSC seems to make up an entity of its own: autoimmune sclerosing cholangitis.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S1089326102000077; http://dx.doi.org/10.1016/s1089-3261(02)00007-7; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=0036311149&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/12122860; https://linkinghub.elsevier.com/retrieve/pii/S1089326102000077; http://linkinghub.elsevier.com/retrieve/pii/S1089326102000077; http://api.elsevier.com/content/article/PII:S1089326102000077?httpAccept=text/xml; http://api.elsevier.com/content/article/PII:S1089326102000077?httpAccept=text/plain; http://dx.doi.org/10.1016/s1089-3261%2802%2900007-7; https://dx.doi.org/10.1016/s1089-3261%2802%2900007-7
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know